trending Market Intelligence /marketintelligence/en/news-insights/trending/f7Bv83Awh-C7d0FAqXBjGg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Braeburn Pharmaceuticals withdraws IPO

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Braeburn Pharmaceuticals withdraws IPO

Braeburn Pharmaceuticals Inc. withdrew plans for an IPO due to uncertainty in the U.S. healthcare industry, Reuters reported.

The Princeton, N.J.-based company was looking to offer 7.7 million shares in the $18 per share to $21 per share range but will consider such a move at a later date.

Apple Tree Partners, a private equity and venture capital firm, is the sole shareholder of Braeburn Pharmaceuticals, which manufactures implants for opioid addiction.